Mizuho Securities USA’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-55,280
Closed -$5.62M 259
2021
Q2
$5.62M Sell
55,280
-53,845
-49% -$5.46M 0.45% 32
2021
Q1
$11M Buy
+109,125
New +$11.2M 1.05% 11
2020
Q4
Sell
-12,500
Closed -$1.25M 211
2020
Q3
$1.25M Sell
12,500
-39,200
-76% -$4.06M 0.09% 96
2020
Q2
$5.12M Buy
+51,700
New +$5.13M 0.34% 43
2020
Q1
Sell
-11,250
Closed -$1.12M 125
2019
Q4
$1.12M Buy
+11,250
New +$1.12M 0.06% 98

Other funds holding CELU

Mizuho Securities USA's CELU Position: Q3 2021 in Review

Mizuho Securities USA sold out of Celularity (CELU) in Q3 2021, closing a stake of 55,280 shares — an estimated $5.62M sold.

Mizuho Securities USA first reported a position in CELU in Q4 2019 and held it in 5 quarters. The position peaked at $11M in Q1 2021. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • Mizuho Securities USA reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • Mizuho Securities USA sold 55,280 Celularity shares in Q3 2021, an estimated $5.62M.
  • Mizuho Securities USA first reported a position in Celularity in Q4 2019 and held it in 5 quarters.
  • Mizuho Securities USA's Celularity position peaked at $11M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Mizuho Securities USA's 13F filing for Q3 2021, filed 28 Oct 2021.